Cargando…
Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine
Elevated prostate-specific antigen (PSA) levels often lead to unnecessary and possibly harmful transrectal ultrasound guided biopsy, e.g. when the biopsy is negative or contains only low-grade insignificant cancer, unlikely to become symptomatic in the man’s normal lifespan. A model based on four-ka...
Autores principales: | Fredsøe, Jacob, Rasmussen, Martin, Tin, Amy L., Vickers, Andrew J., Borre, Michael, Sørensen, Karina D., Lilja, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452554/ https://www.ncbi.nlm.nih.gov/pubmed/36071094 http://dx.doi.org/10.1038/s41598-022-19460-6 |
Ejemplares similares
-
Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP
por: Fredsøe, Jacob, et al.
Publicado: (2023) -
Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer
por: Scuderi, Simone, et al.
Publicado: (2023) -
Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imaging
por: de Almeida S, Ricardo, et al.
Publicado: (2023) -
UCAP: A Framework for Accelerator Controls Data Processing @ CERN
por: Cseppentő, Lajos, et al.
Publicado: (2022) -
High-Throughput and Automated Acoustic Trapping of Extracellular Vesicles to Identify microRNAs With Diagnostic Potential for Prostate Cancer
por: Ku, Anson, et al.
Publicado: (2021)